Menu
This security has been delisted
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

-1.230%
-0.06
-1.230%
-

-

 
07:45 / Stuttgart Stock Exchange WKN: A2P4JE / Name: Protara Therapeutics / Stock / Biotechnology & Medical Research / Micro Cap /

Protara Therapeutics Inc. Stock

A loss of -1.230% shows a downward development for Protara Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Protara Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Protara Therapeutics Inc. in the next few years

Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Cons
?
S********** s********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Protara Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Protara Therapeutics Inc. -1.230% 5.333% -1.250% -11.402% 6.278% 72.993% -71.786%
India Globalization Capital -2.340% 5.785% -9.859% -16.340% 7.563% -13.776% -83.379%
BioInvent International AB 0.000% 6.929% 14.200% 6.134% 6.331% -8.640% -42.230%
Neurosearch As Nam. 0.760% 4.921% 1.912% -18.377% 5.964% -21.848% -21.154%